TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive NCAB To Study Recommendations On Cooperative Groups, Coordination Of NCI Treatment Programs June 20, 1975
TCL Archive In Brief: Komen Foundation Awards Honor Gingell, Osborne, Freeman; Tobacco Regulation Urged October 21, 1994
